Plus   Neg

QinetiQ Q1 Order Intake Strong; Buys Naimuri For GBP 25 Mln - Quick Facts

QinetiQ Group plc (QQ.L) said that its order intake throughout the first quarter continued to be strong, despite COVID-19 related disruption in all of its markets. But, revenue and profit have been impacted by the disruption. The company's cost management actions has reduced the impact on profitability and delivered a strong cash performance.

In addition, QinetiQ announced the acquisition of Naimuri on a cash-free, debt-free basis for 25 million pounds. Naimuri is a software development and data analytics company, providing agile cloud-based services and technology to the UK Intelligence and Law Enforcement communities.

In the 12 months to 31 July 2020, Naimuri expects to deliver in excess of 9 million pounds revenue and 2 million pounds EBITDA.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT